July 7, 2017 by Megan Bard Gang Han, PhD, associate professor of biochemistry & molecular pharmacology at University of Massachusetts Medical School. Credit: UMass Medical School

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including early stage tumor detection because of the enhanced MRI contrast, according to Dr. Han, associate professor of biochemistry & molecular pharmacology at University of Massachusetts Medical School.

MRI is one of the most widely used, noninvasive and versatile imaging tools for clinical detection, staging and monitoring of malignancy, without the need for ionizing radiation or harmful radionuclides.

The most frequently employed contrast agents used in MRI are gadolinium (Gd)-based, since they do not provoke an immune response in cells. However, such compounds require high doses of intravenous administration and are retained in the body's organs.

In the search for alternative, Han and colleagues focused on proteins, which are naturally occurring nanomaterials. For example, the protein-bound nanoparticle Abraxane can be used to treat metastatic breast cancer. In the same way, protein scaffolds that encapsulate metal-based nanoparticulate contrast agents also appear to enhance the effectiveness of contrast agents.

In a paper published June 26 in Nano Letters, ACS Publications, Han and colleagues outlined how human transferrin (Tf) proteins can be used to create an MRI contrast nanoprobe by mimicking the natural process to form special nanoparticles called gadolinium biomineralized human transferrin protein-based nanoparticles or Gd@TfNP.

"The Gd@TfNPs preserve the functions of Tf very well, possess superior chemical and physical properties, and are brighter compared to the Gd-based agents currently in use," Han said, adding that the nanoparticles could also be used as tumor-targeting and systematically clearable contrast agents for MR detection of early-stage tumors.

"Such probes can immediately leave the tumor sites after delivery and we could track the overall process by MRI. Such a technique might be useful not only for visualizing tumor therapies, but for optimizing drug dose and evaluating clinical results," said Yang Zhao, MD, PhD, of the Second Hospital of Tianjin Medical University and the paper's first author.

Explore further: Better contrast agents based on nanoparticles

More information: Yang Zhao et al, Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes, Nano Letters (2017). DOI: 10.1021/acs.nanolett.7b00828

Scientists at the University of Basel have developed nanoparticles which can serve as efficient contrast agents for magnetic resonance imaging. This new type of nanoparticles produce around ten times more contrast than the ...

Researchers from PSG College of Technology, India have developed nano-contrast agents for magnetic resonance imaging (MRI) as well as optical imaging of cancer cells. This report will appear in the forthcoming issue of the ...

Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based contrast agenta chemical "dye" used to enhance the visibility of internal body structures in magnetic resonance imaging ...

Imaging probes that specifically target tumors can provide more sensitive and relevant information about the tumor compared to conventional, non-specific probes. Additionally, targeted probes can improve tumor detection, ...

Being able to view tumor blood vessels without surgery or potent dyes can improve our understanding of the environment in which a tumor grows. Now, a team of researchers, including Chang-Tong Yang from the A*STAR Singapore ...

Gadolinium, one of the rare earth elements, is used as a contrast agent that enhances the quality of MRI examinations of internal organs and tissues. Researchers from Charit - Universittsmedizin Berlin (NeuroCure Clinical ...

In today's increasingly powerful electronics, tiny materials are a must as manufacturers seek to increase performance without adding bulk.

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including ...

AMOLF researchers have developed nanoscale strings whose motion can be converted to light signals with unprecedented strength. This could allow for extremely precise sensors and comes with an important side effect. "Analogous ...

Scientists have created new 2-D nanostructured surfaces which appear as realistic 3-D objects including shading and shadows - using cutting edge nano-engineering.

One afternoon, Carnegie Mellon University Materials Science and Engineering (MSE)'s Mohammad Islam walked into colleague Paul Salvador's office and asked what the biggest problem was in photocatalysis that he'd like to be ...

As embedded intelligence is finding its way into ever more areas of our lives, fields ranging from autonomous driving to personalized medicine are generating huge amounts of data. But just as the flood of data is reaching ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

More here:
Researchers develop tumor-targeting MRI contrast based on human ... - Phys.Org